[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2027 Global Active Pharmaceutical Ingredient Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 112 pages | ID: 2A61D4CF04DFEN
Maia Research

US$ 3,460.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The worldwide market for Active Pharmaceutical Ingredient is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Bayer AG
Pfizer Inc.
Novartis AG
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.

Major Types Covered
Synthetic chemical API
Branded/ Innovative
Generic/Non- Branded
Biological API
Biotech
Biosimilar
High potency active pharmaceutical ingredients(HPAPI)

Major Applications Covered
Captive (or in-house) Manufacturing
Contract Manufacturing

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Active Pharmaceutical Ingredient Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Active Pharmaceutical Ingredient Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE ACTIVE PHARMACEUTICAL INGREDIENT MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY TYPE

5.1 Synthetic chemical API
5.2 Branded/ Innovative
5.3 Generic/Non- Branded
5.4 Biological API
5.5 Biotech
5.6 Biosimilar
5.7 High potency active pharmaceutical ingredients(HPAPI)

6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY APPLICATION

6.1 Captive (or in-house) Manufacturing
6.2 Contract Manufacturing

7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Teva Pharmaceutical Industries Ltd.
  8.1.1 Teva Pharmaceutical Industries Ltd. Profile
  8.1.2 Teva Pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Teva Pharmaceutical Industries Ltd. Product/Solution Launches and Enhancements Analysis
  8.1.4 Teva Pharmaceutical Industries Ltd. Business Overview/Recent Development/Acquisitions
8.2 Sun Pharmaceutical Industries Ltd.
  8.2.1 Sun Pharmaceutical Industries Ltd. Profile
  8.2.2 Sun Pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Sun Pharmaceutical Industries Ltd. Product/Solution Launches and Enhancements Analysis
  8.2.4 Sun Pharmaceutical Industries Ltd. Business Overview/Recent Development/Acquisitions
8.3 Bayer AG
  8.3.1 Bayer AG Profile
  8.3.2 Bayer AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Bayer AG Product/Solution Launches and Enhancements Analysis
  8.3.4 Bayer AG Business Overview/Recent Development/Acquisitions
8.4 Pfizer Inc.
  8.4.1 Pfizer Inc. Profile
  8.4.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Pfizer Inc. Product/Solution Launches and Enhancements Analysis
  8.4.4 Pfizer Inc. Business Overview/Recent Development/Acquisitions
8.5 Novartis AG
  8.5.1 Novartis AG Profile
  8.5.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Novartis AG Product/Solution Launches and Enhancements Analysis
  8.5.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.6 Boehringer Ingelheim International GmbH
  8.6.1 Boehringer Ingelheim International GmbH Profile
  8.6.2 Boehringer Ingelheim International GmbH Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Boehringer Ingelheim International GmbH Product/Solution Launches and Enhancements Analysis
  8.6.4 Boehringer Ingelheim International GmbH Business Overview/Recent Development/Acquisitions
8.7 F. Hoffmann-La Roche Ltd.
  8.7.1 F. Hoffmann-La Roche Ltd. Profile
  8.7.2 F. Hoffmann-La Roche Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 F. Hoffmann-La Roche Ltd. Product/Solution Launches and Enhancements Analysis
  8.7.4 F. Hoffmann-La Roche Ltd. Business Overview/Recent Development/Acquisitions
8.8 Merck & Co., Inc.
  8.8.1 Merck & Co., Inc. Profile
  8.8.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Merck & Co., Inc. Product/Solution Launches and Enhancements Analysis
  8.8.4 Merck & Co., Inc. Business Overview/Recent Development/Acquisitions

9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Active Pharmaceutical Ingredient Production Analysis from 2015-2020
10.4 North America Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
10.5 North America Active Pharmaceutical Ingredient Import and Export from 2015-2020
10.6 North America Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
10.7 North America Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Active Pharmaceutical Ingredient by Country (United States, Canada)
  10.8.1 North America Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  10.8.2 North America Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
10.9 North America Active Pharmaceutical Ingredient Market PEST Analysis

11 EUROPE

11.1 Europe Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Active Pharmaceutical Ingredient Production Analysis from 2015-2020
11.4 Europe Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
11.5 Europe Active Pharmaceutical Ingredient Import and Export from 2015-2020
11.6 Europe Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
11.7 Europe Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Active Pharmaceutical Ingredient by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  11.8.2 Europe Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
11.9 Europe Active Pharmaceutical Ingredient Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Active Pharmaceutical Ingredient Production Analysis from 2015-2020
12.4 Asia-Pacific Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
12.5 Asia-Pacific Active Pharmaceutical Ingredient Import and Export from 2015-2020
12.6 Asia-Pacific Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Active Pharmaceutical Ingredient by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Active Pharmaceutical Ingredient Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Active Pharmaceutical Ingredient Production Analysis from 2015-2020
13.4 Latin America Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
13.5 Latin America Active Pharmaceutical Ingredient Import and Export from 2015-2020
13.6 Latin America Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Active Pharmaceutical Ingredient by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  13.8.2 Latin America Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
13.9 Latin America Active Pharmaceutical Ingredient Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Active Pharmaceutical Ingredient Production Analysis from 2015-2020
14.4 Middle East & Africa Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
14.5 Middle East & Africa Active Pharmaceutical Ingredient Import and Export from 2015-2020
14.6 Middle East & Africa Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Active Pharmaceutical Ingredient by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Active Pharmaceutical Ingredient Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET FROM 2020-2027

15.1 Future Forecast of the Global Active Pharmaceutical Ingredient Market from 2020-2027 Segment by Region
15.2 Global Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

LIST OF TABLES AND FIGURES

Global Active Pharmaceutical Ingredient Market Value ($) and Growth Rate of Active Pharmaceutical Ingredient from 2015-2027
Global Active Pharmaceutical Ingredient Production and Growth Rate Segment by Product Type from 2015-2027
Global Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by Application from 2015-2027
Figure Active Pharmaceutical Ingredient Picture
Table Product Specifications of Active Pharmaceutical Ingredient
Table Driving Factors for this Market
Table Industry News of Active Pharmaceutical Ingredient Market
Figure Value Chain Status of Active Pharmaceutical Ingredient
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Active Pharmaceutical Ingredient Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Synthetic chemical API of Active Pharmaceutical Ingredient
Figure Branded/ Innovative of Active Pharmaceutical Ingredient
Figure Generic/Non- Branded of Active Pharmaceutical Ingredient
Figure Biological API of Active Pharmaceutical Ingredient
Figure Biotech of Active Pharmaceutical Ingredient
Figure Biosimilar of Active Pharmaceutical Ingredient
Figure High potency active pharmaceutical ingredients(HPAPI) of Active Pharmaceutical Ingredient
Table Global Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Captive (or in-house) Manufacturing of Active Pharmaceutical Ingredient
Figure Contract Manufacturing of Active Pharmaceutical Ingredient
Table Global Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Active Pharmaceutical Ingredient
Figure Online Channel of Active Pharmaceutical Ingredient
Table Teva Pharmaceutical Industries Ltd. Profile (Company Name, Plants Distribution, Sales Region)
Figure Teva Pharmaceutical Industries Ltd. Sales and Growth Rate from 2015-2020
Figure Teva Pharmaceutical Industries Ltd. Revenue ($) and Global Market Share from 2015-2020
Table Teva Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sun Pharmaceutical Industries Ltd. Profile (Company Name, Plants Distribution, Sales Region)
Figure Sun Pharmaceutical Industries Ltd. Sales and Growth Rate from 2015-2020
Figure Sun Pharmaceutical Industries Ltd. Revenue ($) and Global Market Share from 2015-2020
Table Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer AG Sales and Growth Rate from 2015-2020
Figure Bayer AG Revenue ($) and Global Market Share from 2015-2020
Table Bayer AG Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Inc. Sales and Growth Rate from 2015-2020
Figure Pfizer Inc. Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Inc. Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim International GmbH Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim International GmbH Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim International GmbH Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim International GmbH Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table F. Hoffmann-La Roche Ltd. Profile (Company Name, Plants Distribution, Sales Region)
Figure F. Hoffmann-La Roche Ltd. Sales and Growth Rate from 2015-2020
Figure F. Hoffmann-La Roche Ltd. Revenue ($) and Global Market Share from 2015-2020
Table F. Hoffmann-La Roche Ltd. Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck & Co., Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co., Inc. Sales and Growth Rate from 2015-2020
Figure Merck & Co., Inc. Revenue ($) and Global Market Share from 2015-2020
Table Merck & Co., Inc. Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Active Pharmaceutical Ingredient Production Value ($) by Region from 2015-2020
Table Global Active Pharmaceutical Ingredient Production Value Share by Region from 2015-2020
Table Global Active Pharmaceutical Ingredient Production by Region from 2015-2020
Table Global Active Pharmaceutical Ingredient Consumption Value ($) by Region from 2015-2020
Table Global Active Pharmaceutical Ingredient Consumption by Region from 2015-2020
Table North America Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table North America Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table North America Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table North America Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table North America Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table North America Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure North America Active Pharmaceutical Ingredient Market PEST Analysis
Table Europe Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Europe Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Europe Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Europe Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Europe Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Europe Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Europe Active Pharmaceutical Ingredient Market PEST Analysis
Table Asia-Pacific Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Asia-Pacific Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Asia-Pacific Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Asia-Pacific Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Asia-Pacific Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market PEST Analysis
Table Latin America Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Latin America Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Latin America Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Latin America Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Latin America Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Latin America Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Latin America Active Pharmaceutical Ingredient Market PEST Analysis
Table Middle East & Africa Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Middle East & Africa Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Middle East & Africa Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Middle East & Africa Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Middle East & Africa Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market PEST Analysis
Table Global Active Pharmaceutical Ingredient Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Region (2020-2027)
Table Global Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Type (2020-2027)
Table Global Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by Application (2020-2027)


More Publications